Literature DB >> 28119252

What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion?

Kyohei Yamaji1, Lorenz Räber, Stephan Windecker.   

Abstract

Mesh:

Year:  2017        PMID: 28119252     DOI: 10.4244/EIJV12I14A277

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  3 in total

1.  Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes.

Authors:  Xucheng Lv; Li Shen; Yizhe Wu; Lei Ge; Jiahui Chen; Jiasheng Yin; Rui Wang; Meng Ji; Bin Hong; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-28       Impact factor: 2.357

2.  Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.

Authors:  J Elias; I M van Dongen; R P Kraak; R Y G Tijssen; B E P M Claessen; J G P Tijssen; R J de Winter; J J Piek; J J Wykrzykowska; J P S Henriques
Journal:  Neth Heart J       Date:  2017-07       Impact factor: 2.380

3.  Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique.

Authors:  Christine Reichart; Jochen Wöhrle; Sinisa Markovic; Wolfgang Rottbauer; Julia Seeger
Journal:  BMC Cardiovasc Disord       Date:  2019-01-18       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.